Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 128 matching records.
128 results — page 1 of 6
- Level DAnimal StudyPubMed
Neuroprotective Potential of Conditioned Medium from Adipose and Liver Mesenchymal Stem Cells in a Rat Model of Global Cerebral Ischemia-reperfusion Injury.
Animal Study on Stroke Research, published in Curr Mol Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Mol Med - Level DLaboratory StudyPubMed
Conditioned medium from human adipose-derived mesenchymal stromal cells can modulate cell migration and morphology of keratinocytes in vitro.
Laboratory Study on Chronic Wound, published in Hum Cell (2026) — summary generated from the PubMed abstract.
- 2026
Hum Cell - Level DLaboratory StudyPubMed
Effects of nanosilymarin and conditioned medium of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells co-cultured with HeLa cells.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in BMC Complement Med Ther (2026) — summary generated from the PubMed abstract.
- 2026
BMC Complement Med Ther - Level DNarrative ReviewEurope PMC
Conditioned medium from mesenchymal stem cells: Towards skin tissue engineering and wound healing
Narrative Review on Diabetic Foot, Chronic Wound, Burns, Scar, published in Iran J Basic Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
Iran J Basic Med Sci - Level DLaboratory StudyPubMed
In vitro exploration of the therapeutic potential of mesenchymal stem cell conditioned medium in endometriosis treatment by targeting apoptosis and cellular migration.
Laboratory Study, published in Int J Reprod Biomed (2026) — summary generated from the PubMed abstract.
- 2026
Int J Reprod Biomed - Level DLaboratory StudyPubMed
Mesenchymal stem cell-derived conditioned medium demonstrates novel antibacterial effects in ocular bacterial infections.
Laboratory Study on Immune Modulation, published in Infect Immun (2026) — summary generated from the PubMed abstract.
- 2026
Infect Immun - Level DLaboratory StudyPubMed
Adipose-derived mesenchymal stem cell-conditioned medium promotes corneal epithelial cell wound healing in vitro through cell-cycle activation.
Laboratory Study on Chronic Wound, published in Exp Eye Res (2026) — summary generated from the PubMed abstract.
- 2026
Exp Eye Res - Level DAnimal StudyPubMed
Therapeutic potential of adipose-derived mesenchymal stem/stromal cells conditioned medium versus adipose-derived mesenchymal stem/stromal cells on treatment of polycystic ovary In-vivo.
Animal Study on Type 2 Diabetes, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Cell - Level DLaboratory StudyPubMed
Comparative regenerative mechanisms of adipose-derived mesenchymal stem cell- and conditioned medium-loaded three-dimensional bioprinted hydrogels in chronic diabetic wounds.
Laboratory Study on Diabetic Foot, Immune Modulation, published in Regen Biomater (2026) — summary generated from the PubMed abstract.
- 2026
Regen Biomater - Level DLaboratory StudyPubMed
Adipose-derived mesenchymal stem cell-conditioned medium and proliferation of intestinal stem cells in mesenteric ischemia and reperfusion.
Laboratory Study on Systemic / IV, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level DLaboratory StudyPubMed
Mesenchymal stem cell-derived conditioned medium demonstrates antifungal activity against ocular isolates of Candida albicans and Aspergillus flavus: a proof-of-concept study.
Laboratory Study on Face & Skin, published in Exp Eye Res (2026) — summary generated from the PubMed abstract.
- 2026
Exp Eye Res - Level DAnimal StudyPubMed
Conditioned medium from human adipose-derived mesenchymal stem cells attenuates cardiac injury induced by Movento in male rats: role of oxidative stress and inflammation.
Animal Study on Cardiovascular Disease, published in BMC Pharmacol Toxicol (2025) — summary generated from the PubMed abstract.
- 2025
BMC Pharmacol Toxicol3 citations - Level CProspective StudyPubMed
New Insights on the miRNA Role in Diabetic Tendinopathy: Adipose-Derived Mesenchymal Stem Cell Conditioned Medium as a Potential Innovative Epigenetic-Based Therapy for Tendon Healing.
Prospective Study on Tendon Injury, Chronic Wound, published in Biomolecules (2025) — summary generated from the PubMed abstract.
- 2025
Biomolecules1 citations - Level DLaboratory StudyPubMed
The potential of Spirulina maxima extract-treated conditioned medium from adipose-derived mesenchymal stem cells for hair growth promoting effect on human dermal papilla cells.
Laboratory Study on Hair Loss, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level DAnimal StudyPubMed
Repair effect of adipose-derived mesenchymal stem cell-conditioned medium on cyclophosphamide-induced ovarian injury in mice.
Animal Study on Hair & Scalp, Systemic / IV, published in Reprod Toxicol (2025) — summary generated from the PubMed abstract.
- 2025
Reprod Toxicol - Level CProspective StudyPubMed
Safety assessment of multiple systemic administration of human mesenchymal stem cell-conditioned medium for various chronic diseases.
Prospective Study with a reported sample of 55 on Chronic Inflammation, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
- n = 55
PLoS One1 citations - Level DAnimal StudyPubMed
TNF-Stimulated Gene-6, Part of Extracellular Vesicles in Adipose Tissue-Derived Mesenchymal Stem Cell Concentrated Conditioned Medium, Affects Microglial Activity.
Animal Study on Chronic Inflammation, published in J Neuroimmune Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
J Neuroimmune Pharmacol2 citations - Level DAnimal StudyPubMed
Conditioned medium from adipose mesenchymal stromal cells stimulated with pituitary adenylate cyclase-activating polypeptide (PACAP) mitigates RINm5F pancreatic β-cell dysfunction.
Animal Study on Immune Modulation, published in Mol Biol Rep (2025) — summary generated from the PubMed abstract.
- 2025
Mol Biol Rep1 citations - Level CProspective StudyPubMed
Intravenous Administration of Human-Derived Mesenchymal Stem Cell-Conditioned Medium for Patients with General Malaise.
Prospective Study with a reported sample of 19 on Chronic Inflammation, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 19
J Clin Med - Level DAnimal StudyPubMed
The stereological investigation of conditioned medium originated from human adipose tissue-derived mesenchymal stem cells and platelet-rich plasma effects on polycystic ovary syndrome in a rat model.
Animal Study on Scar, published in Zygote (2025) — summary generated from the PubMed abstract.
- 2025
Zygote - Level DAnimal StudyPubMed
Mesenchymal stem cell-conditioned medium accelerates type 2 diabetic wound healing by targeting TNF and chemokine signaling.
Animal Study on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Front Cell Dev Biol (2025) — summary generated from the PubMed abstract.
- 2025
Front Cell Dev Biol - Level DAnimal StudyPubMed
Evaluation of conditioned medium from Sertoli cells as a potential inducer of in vitro germ cell differentiation of bovine fetal mesenchymal stem cells (MSCs).
Animal Study, published in Anim Reprod (2025) — summary generated from the PubMed abstract.
- 2025
Anim Reprod - Level DAnimal StudyEurope PMC
Tissue regenerative potential of human dental pulp mesenchymal stem cell conditioned medium in wound healing of the medicinal leech
Animal Study on Chronic Wound, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level CCase Report / SeriesPubMed
Neurotrauma induced retinal basement membrane COL4A1 defects are restored by adipose tissue derived mesenchymal stem cell concentrated conditioned medium.
Case Report / Series on Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406